Companies: 48,874 Total Market Cap: 132460447025120.92

Pfizer

NYSE: PFE
Healthcare Drug Manufacturers - General
Rank #132
Market Cap 130.76 B
Volume 31.48 M
Price 23
Change (%) 0.74%
Country or region United States United States

Pfizer's latest marketcap:

130.76 B

As of 05/19/2025, Pfizer's market capitalization has reached $130.76 B. According to our data, Pfizer is the 132th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 130.76 B
Revenue (ttm) 62.46 B
Net Income (ttm) 7.88 B
Shares Out 5.69 B
EPS (ttm) 1.38
Forward PE 8.03
Ex-Dividend Date 05/09/2025
Earnings Date 04/29/2025
Market Cap Chart
Data Updated: 05/19/2025

Pfizer's yearly market capitalization.

Pfizer has seen its market value drop from $162.23 B to $130.76 B since 1998, representing a total decrease of 19.39% and an annual compound decline rate (CAGR) of 0.81%.
Date Market Cap Change (%)
05/19/2025 $130.76 B -13.67%
12/31/2024 $150.35 B -7.51%
12/29/2023 $162.56 B -43.48%
12/30/2022 $287.63 B -13.22%
12/31/2021 $331.44 B 61.99%
12/31/2020 $204.60 B -5.64%
12/31/2019 $216.83 B -14.07%
12/31/2018 $252.32 B 16.87%
12/29/2017 $215.90 B 9.54%
12/30/2016 $197.10 B -1.09%
12/31/2015 $199.26 B 1.53%
12/31/2014 $196.27 B -1.13%
12/31/2013 $198.52 B 7.51%
12/31/2012 $184.65 B 11%
12/30/2011 $166.35 B 18.6%
12/31/2010 $140.25 B -4.45%
12/31/2009 $146.78 B 22.92%
12/31/2008 $119.42 B -23.08%
12/31/2007 $155.24 B -16.87%
12/29/2006 $186.75 B 8.64%
12/30/2005 $171.90 B -15.11%
12/31/2004 $202.51 B -24.89%
12/31/2003 $269.62 B 43.13%
12/31/2002 $188.38 B -24.81%
12/31/2001 $250.53 B -13.68%
12/29/2000 $290.22 B 131.09%
12/31/1999 $125.58 B -22.59%
12/31/1998 $162.23 B

Company Profile

Pfizer Inc. Overview

Pfizer Inc. is a global biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of medicines and vaccines. Headquartered in New York, the company serves healthcare providers, wholesalers, and government agencies worldwide.

Key Therapeutic Areas & Brands

  • Cardiovascular & Migraine: Eliquis, Nurtec ODT/Vydura, Zavzpret, Premarin family
  • Infectious Diseases: Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, Trumenba
  • COVID-19 Solutions: Comirnaty, Paxlovid (with potential mRNA and antiviral developments)
  • Chronic Immune & Inflammatory Diseases: Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, Cibinqo
  • Rare Diseases & Endocrinology: Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, Genotropin
  • Sterile Injectables & Anti-Infectives: Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, Panzyga
  • Oncology & Biosimilars: Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, Talzenna

Business Segments

In addition to its core pharmaceutical operations, Pfizer is involved in contract manufacturing, supplying products to hospitals, clinics, pharmacies, and integrated delivery systems.

Strategic Collaborations

The company partners with leading healthcare organizations, including:

  • Bristol-Myers Squibb Company
  • Astellas Pharma US, Inc.
  • Merck KGaA
  • BioNTech SE

Founded: 1849 | Headquarters: New York, New York

Frequently Asked Questions

As of 05/19/2025, Pfizer (including the parent company, if applicable) has an estimated market capitalization of $130.76 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Pfizer global market capitalization ranking is approximately 132 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1849
IPO Date n/a
Employees n/a
CEO Albert Bourla
Sector Healthcare
Industry Drug Manufacturers - General
Address 66 Hudson Boulevard East
New York, New York 10001-2192
United States
Website https://www.pfizer.com
People Also Watch
Eli Lilly
755.11 0.74%
JNJ
152.49 0.74%
AbbVie
185.71 0.74%
Novo Nordisk
67.02 0.74%